|
RMI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.83049996960972E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87559999997866E-06 |
| Normal-vs-Stage2 |
2.01899999999755E-05 |
| Normal-vs-Stage3 |
4.47129999692208E-08 |
| Normal-vs-Stage4 |
7.48649997550643E-09 |
| Stage1-vs-Stage2 |
3.693200E-01 |
| Stage1-vs-Stage3 |
1.926160E-01 |
| Stage1-vs-Stage4 |
6.075500E-03 |
| Stage2-vs-Stage3 |
9.729000E-01 |
| Stage2-vs-Stage4 |
2.584400E-01 |
| Stage3-vs-Stage4 |
1.652160E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17269999769343E-08 |
| Normal-vs-AfricanAmerican |
1.204810E-01 |
| Normal-vs-Asian |
4.43079999999929E-05 |
| Caucasian-vs-AfricanAmerican |
4.128200E-02 |
| Caucasian-vs-Asian |
9.107800E-01 |
| AfricanAmerican-vs-Asian |
8.573600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.92959999592668E-08 |
| Normal-vs-Female |
9.18550000506002E-08 |
| Male-vs-Female |
4.755400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.572840E-04 |
| Normal-vs-Age(41-60Yrs) |
2.61160004733085E-09 |
| Normal-vs-Age(61-80Yrs) |
3.52939999448409E-08 |
| Normal-vs-Age(81-100Yrs) |
1.939120E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.667950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.082360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.899800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.372200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.274400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.324000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.084600E-01 |
| Classical-VS-Follicular |
1.044370E-02 |
| Classical-VS-Other |
5.407800E-01 |
| Classical-VS-Normal |
2.24439999996218E-06 |
| Tall-VS-Follicular |
5.385400E-01 |
| Tall-VS-Other |
9.261800E-01 |
| Tall-VS-Normal |
1.402610E-04 |
| Follicular-VS-Other |
8.086600E-01 |
| Follicular-VS-Normal |
8.19949996788694E-09 |
| Other-VS-Normal |
2.489600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.21239999951418E-07 |
| Normal-vs-N1 |
2.44880000055403E-07 |
| N0-vs-N1 |
2.754400E-01 |
|
|
